This network meta-analysis examined acupuncture-related interventions, including acupoint application, abdominal needle, thunder-fire moxibustion, conventional acupuncture, and ear acupuncture, either alone or combined with usual treatment for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). The study included 3,156 participants and assessed primary outcomes of symptom improvement alongside secondary outcomes such as forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV1/FVC.
Key results indicated statistically significant associations for symptom improvement with acupoint application (OR = 4.97; 95% CrI 3.18–8.24) and abdominal needle (OR = 6.84; 95% CrI 2.59–21.54) compared with usual treatment. Thunder-fire moxibustion was associated with higher FEV1 values (MD = 0.71; 95% CrI 0.50–0.92), while conventional and ear acupuncture showed improvements in FVC and FEV1/FVC, though specific effect sizes for these were not reported.
The authors note that most included trials evaluated acupuncture as an adjunct to usual care. Overall certainty of evidence ranged from moderate to low. Ranking results from SUCRA should be interpreted cautiously and considered together with effect estimates and the certainty of evidence, as they reflect ranking probabilities rather than the magnitude of treatment effects.
Safety data, including adverse events, serious adverse events, discontinuations, and tolerability, were not reported. The authors caution that associations were reported rather than causality, and findings need confirmation by further large-scale and well-designed randomized controlled trials before altering clinical practice.
View Original Abstract ↓
This study aimed to evaluate the efficacy of acupuncture-related interventions for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) using a network meta-analysis.
PubMed, Embase, Cochrane Library, Web of Science, CNKI, VIP, and Wan fang were searched from inception to September 20, 2025. Randomized controlled trials involving patients with AECOPD and evaluating acupuncture-related interventions, alone or in combination with usual treatment, were included. The primary outcome was symptom improvement. Secondary outcomes were forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and FEV1/FVC. A Bayesian network meta-analysis was conducted to synthesize direct and indirect evidence across interventions.
A total of 45 randomized controlled trials involving 3,156 participants were included. Compared with usual treatment, several acupuncture-related interventions were associated with improvements in symptom-related outcomes and pulmonary function parameters. For symptom improvement, acupoint application (AA) and abdominal needle (AN) showed statistically significant associations compared with usual treatment (AA: OR = 4.97, 95% CrI 3.18–8.24; AN: OR = 6.84, 95% CrI 2.59–21.54). For pulmonary function outcomes, thunder-fire moxibustion (TFM) was associated with higher FEV1 values (MD = 0.71, 95% CrI 0.50–0.92), while conventional acupuncture (AC) and ear acupuncture (EAC) were associated with improvements in FVC and FEV1/FVC. Ranking analyses suggested that AN, TFM, AC, and AA/EAC tended to rank relatively higher for symptom improvement, FEV1, FVC, and FEV1/FVC, respectively; however, surface under the cumulative ranking curve (SUCRA) values reflect ranking probabilities rather than the magnitude of treatment effects.
Acupuncture-related interventions may provide potential adjunctive benefits for patients with AECOPD when used in combination with conventional treatment. In this network meta-analysis, several interventions were associated with improvements in symptom-related outcomes and pulmonary function parameters. However, ranking results from SUCRA should be interpreted cautiously and considered together with effect estimates and the certainty of evidence. Given that most included trials evaluated acupuncture as an adjunct to usual care and the overall certainty of evidence ranged from moderate to low, further large-scale and well-designed randomized controlled trials are needed to confirm these findings.
https://www.crd.york.ac.uk/PROSPERO/view/CRD420251080558, identifier CRD420251080558.